Javascript must be enabled to continue!
146 IS SURTAVI RISK MODEL A STEP TOWARDS ‘TAVI RISK SCORE’: TIME TO RETHINK?
View through CrossRef
Introduction
During the design of the SURTAVI trial, a new concept of risk stratification for patients with aortic stenosis, based upon age combined with a fixed number of predefined risk factors including frailty, was proposed. The purpose of this study was to compare the performance of SURTAVI model with surgical risk scores that is, logistic EuroSCORE (LES), EuroSCORE II (ES II) and STS score in predicting 30-day and 1-year mortality in patients selected by the ‘Heart Team’ for Transcatheter Aortic Valve Implantation (TAVI) after formal surgical turn down.
Table 1
SURTAVI Risk Model
Age
Low risk
Intermediate risk
High risk
70–74 years
<2 risk factors
2–3 risk factors
>3 risk factors
75–79 years
no risk factor
1–2 risk factors
>2 risk factors
≥80 years
—
0–1 risk factor
>1 risk factors
Methods
–88 consecutive patients who underwent TAVI in a single institute, via trans-femoral, trans-subclavian, trans-apical and other approaches, were included. LES, ES II and STS score were calculated retrospectively. Patients were classified into low, intermediate and high risk groups according to SURTAVI model (table 1) and surgical risk scores (LES <10, 10–20, >20%, ES II <4, 4–10, >10% and STS <4, 4–10, >10% respectively). Actual 30-day and 1-year mortality was compared.
Results
Mean age was 79.9 years and 39.8% were females. Overall 30-day and 1-year mortality was 7.9% and 25% respectively. There was no statistically significant difference in mortality between low, intermediate and high risk groups according to SURTAVI risk model and other surgical risk scores, both at 30 days and 1 year. Results are summarised in the table 2.
Table 2
30-day mortality (%)
Groups
LES
ES II
STS-score
SURTAVI model
Low risk
8.3
5.9
10.0
16.7
Intermediate risk
11.4
11.1
8.2
11.1
High risk
4.9
5.7
5.3
6.3
p Value
0.562
0.875
1.0
0.376
1-year mortality (%)
Low risk
25.0
23.5
10.0
16.7
Intermediate risk
22.9
19.4
30.6
11.1
High risk
26.8
31.4
26.3
29.7
p Value
0.943
0.502
0.203
0.254
Conclusions
SURTAVI model was no better than other risk scores in predicting mortality, both at 30 days and 1 year, in patients undergoing TAVI after formal surgical turn down. This highlights the deficiencies of proposed SURTAVI model in the TAVI population and places the emphasis on the role of multidisciplinary ‘Heart Team’ in patient selection and need to develop more sophisticated TAVI risk model.
Title: 146 IS SURTAVI RISK MODEL A STEP TOWARDS ‘TAVI RISK SCORE’: TIME TO RETHINK?
Description:
Introduction
During the design of the SURTAVI trial, a new concept of risk stratification for patients with aortic stenosis, based upon age combined with a fixed number of predefined risk factors including frailty, was proposed.
The purpose of this study was to compare the performance of SURTAVI model with surgical risk scores that is, logistic EuroSCORE (LES), EuroSCORE II (ES II) and STS score in predicting 30-day and 1-year mortality in patients selected by the ‘Heart Team’ for Transcatheter Aortic Valve Implantation (TAVI) after formal surgical turn down.
Table 1
SURTAVI Risk Model
Age
Low risk
Intermediate risk
High risk
70–74 years
<2 risk factors
2–3 risk factors
>3 risk factors
75–79 years
no risk factor
1–2 risk factors
>2 risk factors
≥80 years
—
0–1 risk factor
>1 risk factors
Methods
–88 consecutive patients who underwent TAVI in a single institute, via trans-femoral, trans-subclavian, trans-apical and other approaches, were included.
LES, ES II and STS score were calculated retrospectively.
Patients were classified into low, intermediate and high risk groups according to SURTAVI model (table 1) and surgical risk scores (LES <10, 10–20, >20%, ES II <4, 4–10, >10% and STS <4, 4–10, >10% respectively).
Actual 30-day and 1-year mortality was compared.
Results
Mean age was 79.
9 years and 39.
8% were females.
Overall 30-day and 1-year mortality was 7.
9% and 25% respectively.
There was no statistically significant difference in mortality between low, intermediate and high risk groups according to SURTAVI risk model and other surgical risk scores, both at 30 days and 1 year.
Results are summarised in the table 2.
Table 2
30-day mortality (%)
Groups
LES
ES II
STS-score
SURTAVI model
Low risk
8.
3
5.
9
10.
0
16.
7
Intermediate risk
11.
4
11.
1
8.
2
11.
1
High risk
4.
9
5.
7
5.
3
6.
3
p Value
0.
562
0.
875
1.
0
0.
376
1-year mortality (%)
Low risk
25.
0
23.
5
10.
0
16.
7
Intermediate risk
22.
9
19.
4
30.
6
11.
1
High risk
26.
8
31.
4
26.
3
29.
7
p Value
0.
943
0.
502
0.
203
0.
254
Conclusions
SURTAVI model was no better than other risk scores in predicting mortality, both at 30 days and 1 year, in patients undergoing TAVI after formal surgical turn down.
This highlights the deficiencies of proposed SURTAVI model in the TAVI population and places the emphasis on the role of multidisciplinary ‘Heart Team’ in patient selection and need to develop more sophisticated TAVI risk model.
Related Results
Transcatheter aortic valve implantation in degenerated trans-catheter and surgical bioprosthetic aortic valve
Transcatheter aortic valve implantation in degenerated trans-catheter and surgical bioprosthetic aortic valve
Abstract
Background
The moving forward indication of transcatheter aortic valve implantation (TAVI) to younger aortic valve sten...
Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis
Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis
Objective
The effect of postoperative blood flow status on the prognosis of patients with low-gradient severe aortic stenosis (AS) has not been examined. Severe A...
PRIORiTize-TAVI score: a novel clinical tool Predicting moRtalIty Or uRgent TAVI on waiting list
PRIORiTize-TAVI score: a novel clinical tool Predicting moRtalIty Or uRgent TAVI on waiting list
Abstract
Background
Waiting list (WL) for transcatheter aortic valve implantation (TAVI) has been increasing and prioritization ...
Predisposing and precipitating factors of post-operative delirium after transfemoral TAVI
Predisposing and precipitating factors of post-operative delirium after transfemoral TAVI
Abstract
Background
Transcatheter aortic valve implantation (TAVI) represents the treatment of choice for aortic stenosis (AS) p...
Predictors of futility outcomes after TAVI: insights from the France TAVI Registry
Predictors of futility outcomes after TAVI: insights from the France TAVI Registry
Abstract
Background
Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of aortic stenosis and provi...
Comparative Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Frail Elderly Patients: A Multicenter Cohort Study
Comparative Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Frail Elderly Patients: A Multicenter Cohort Study
Background: Aortic stenosis (AS) is a common valvular heart disease affecting the elderly, with Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement...
P3698Long-term durability of transcatheter aortic valve prostheses: results of a center
P3698Long-term durability of transcatheter aortic valve prostheses: results of a center
Abstract
The durability of transcatheter heart valves and long-term clinical outcomes are unknown. The aim of this study was to...
Post-TAVI pacemaker requirement prediction - simple math?
Post-TAVI pacemaker requirement prediction - simple math?
Abstract
Introduction
As transcatheter aortic valve implantation (TAVI) procedures become increasingly common, predicting...

